Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04515394
Title Study of Tepotinib Combined With Cetuximab in Participants Left-Sided Metastatic Colorectal Cancer (mCRC) Acquired Resistance Due to Mesenchymal Epithelial Transition (MET) Amplification
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors EMD Serono Research & Development Institute, Inc.

colorectal cancer


Cetuximab + Tepotinib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST